研究実績

2023論文業績

原著論文

 

1)南園京子、広瀬貴行、西田翔、片野咲、須田遼祐、石川暢夫、岩見大基 移植腎廃絶後の拒絶反応に対する移植腎動脈塞栓療法 日本臨床腎移植学会雑誌 11(1):83~86、2023

2)佐々木元、田邉起、原田浩 サイトメガロウイルス抗体陽性ドナーから陰性レシピエントへの腎移植においてエベロリムスが与える影響 移植 57巻4号 319-323 2023

3)Sho Nishida, Takehiro Ohyama, Kyoko Minamisono, Hajime Sasaki and Daiki Iwami,

RetroperitoneoscopicDonorNephrectomyontheRightSideProvidesEquivalentOutcomesandDonorSafetytoThatontheLeftSide, Transplant Proc. 2023 May;55(4):744-747. doi: 10.1016/j.transproceed.2023.04.030. Epub 2023May 24.

4)Sasaki H, Hasegawa K, Harada H, Takamoto D, Takada Y, Hirano T, Tanabe T, Tanaka H and Miura M  Comparison of humoral response in kidney transplant recipients and donors and healthy volunteers following second dose of SARS-CoV-2 mRNA vaccine

Transplant Proc. 2023 Feb 27;S0041-1345(23)00071-4. doi:10.1016/j.transproceed.2023.02.018.

5)Sasaki H, Hirose T, Oura T, Ma D, Otsuka R, Lassiter G, Susan R P, Reeves P M, Karadagi A, Tomosugi T, Dehnadi A, Matsunami M , Hanekamp I, Schwartz S, Rosales I, Colvin R B, Lee H, Spitzer T R, Cosimi A B, Cippà P E, Fehr T, Kawai T  Selective Bcl-2 inhibition induces apoptosis of hematopoietic stem cells and lymphocytes to promote hematopoietic chimerism and allograft tolerance without myelosuppression.

Sci Transl Med. 2023 Apr 5;15(690):eadd5318.doi: 10.1126/scitranslmed.add5318. Epub 2023 Apr 5.

6)Sasaki H, Tanabe T, Tsuji T, Hotta K  Mechanism and treatment for chronic antibody-mediated rejection in kidney transplant recipients

Int J Urol.2023 Jun 12.doi: 10.1111/iju.15197.

7)Takada Y, Hotta K, Moriya K, Sasaki H, Takamoto T, Higuchi H, Tanabe T, Minami M, Iwasaki S, Tsuji T, Tanaka H  A case of kidney transplantation from a deceased donor with acute kidney injury due to rhabdomyolysis Nephron. 2023 Mar 24. doi: 10.1159/000530340.

8)Iwahara N, Hotta K, Iwami D, Tanabe T, Tanaka Y, Ito Y, Otsuka T, Murai S, Takada Y, Higuchi H, Sasaki H, Hirose T, Harada H and Shinohara N  Analysis of t cell alloantigen response via a direct pathway in kidney transplant recipients with donor specific antibodies Front Immunol. 2023 May 3;14:1164794. doi: 10.3389/fimmu.2023.1164794. eCollection 2023.

9)Iwasaki S, Takahashi K, Katano H, Suzuki T, Sasaki H, Harada H, Takada Y, Makita K, Fukasawa Y, Tsuji T   BK polyomavirus-associated urothelial carcinoma of the bladder with a background of BK polyomavirus nephropathy in a kidney transplant recipient Nephron 2023 Aug 2. doi: 10.1159/000531822.

10)Mitsuke A, Ohbo T, Osako Y, Sakaguchi T, Matsushita R, Yoshino H, Tatarano S, Yamada Y, Sasaki H, Tanabe T, Fukazawa N, Tanaka H, Nishio Y, Enokida H, Harada H.  Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients

Plos One.2023 Oct 11;18(10):e0287059. doi:10.1371/journal.pone.0287059. 

11)Takada Y, Tanabe T, Sasaki S, Tsujimoto T, Hotta K, Okada K, Shiono Y, Minami K, Tanaka H, Harada H  Kidney donor age of 50 years or above is a risk factor for calcineurin inhibitor‐induced nephrotoxicity

Clin Transplant. 2023 Nov 17:e15196. doi: 10.1111/ctr.15196.

12)Ohyama T, Sasaki H, Minamisono K, Nishida S, Iwami D  Orthotopic kidney transplantation from a living renal donor after interventional terapy for bilateral arteriosclerosis obliterans of the iliac arteries: A case report and literature review IJU Case Rep. 2023 Sep 14;6(6):428-432. doi: 10.1002/iju5.12640.

 

著書・総説

1)西田 翔、岩見大基、後腹膜鏡下ドナー腎採取術(右・左)、臨泌77巻4号2023年増刊

2)八木澤隆:腎移植、令和5年度透析療法従事職員研修テキスト、日本腎臓財団、p145-162、2023

3)八木澤隆:第15章 腎移植、血液浄化療法ハンドブック、2023、透析療法合同専門委員会企画、協同医書出版社、p363-376、2023

4)木村貴明、岩見大基: CKD-MBDの治療 腎移植後, 腎と透析, 95(3): 352-533, 2023.